STIMIT Activator 1 IDE Study
Stimit AG · NCT05883163
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 40
- US sites recruiting
- 3
- Study start
- January 24, 2024
- Record last updated
- November 14, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The study is a prospective, multi-center, randomized, controlled study using adaptive design to assess the evidence of safety and performance of the STIMIT Activator 1 System in the treatment of patients who have been mechanically ventilated for up to 7 days and are predicted to require additional minimum 48 hours of mechanical ventilation or longer.
Being studied: Stimit Activator 1
Conditions: Diaphragm Issues
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Are 21 years or older, and,
- Have recently been placed on invasive MV (enroll and randomized as soon as possible after intubation), and have received no more than 7 days of MV
- Are predicted to remain on mechanical ventilation for an additional 48 hours or longer post randomization
Exclusion Criteria
- Patients that are actively treated with continuous infusion of neuromuscular blocking agents beyond the enrollment period.
- Medical condition known to affect the phrenic nerve or respiratory muscles (examples of possible medical conditions that could affect the phrenic nerve provided in Annex 1 below).
- Any patients with ICP probe.
- Patients with metallic device implants or body penetrating metallic devices in the upper body area within 30cm (12inches) from the coils; known anatomy or devices in the neck area (e.g., ECMO cannulas in the neck area, collars or cranial appliances) that would interfere with headset placement or stimulation.
- Any non-removable electrical / electronic device (device internal or external) that may be prone to interaction with, or interference from the STIMIT Activator, such as pacemakers, implantable defibrillators, implanted medication pumps, bio-stimulators, deep brain stimulators, implanted nerve stimulator, deep brain stimulators or cochlear device implants.
- BMI >40.
- Cardiogenic or septic shock with ongoing severe hemodynamic instability that cannot be stabilized within the enrollment period.
- Physician thinks that the patient will not tolerate initial installation of the STIMIT respiratory sensor.
- Anticipating withdrawal of life support and/or shift to palliation as the goal of care.
- Known to be pregnant.
- Participating in another clinical trial studying an experimental Intervention that could affect the study primary outcome.
- Patients whose ultrasonographic assessment of right-sided diaphragmatic thickness would be too difficult (e.g. local subcutaneous emphysema surrounding the zone of apposition, large dressings in the zone of apposition that cannot be removed).
- Patients with neck condition that would not allow placing the coils on the neck (e.g. open wounds that cannot be covered, skin at risk for burns).
- Patients with significant spontaneous efforts (P0.1 \< - 2) that would not be at risk for diaphragmatic atrophy/ dysfunction.
Recruiting US locations
Yale New Haven Hospital
New Haven, CT 06510
Site contact: Rodolfo Nelson Molina · Rodolfo.molina@yale.edu
Beth Israel Deaconess Medical Center
Boston, MA 02215
Site contact: Matthew Killam · mkillam@bidmc.harvard.edu
University of Virginia Medical Center
Charlottesville, VA 22908
Site contact: Hailey Russo · SXU9RN@uvahealth.org
Study contacts (from the official record)
- Tsiry Rabemahefa · 218-329-7356 · tsiry.rabemahefa@stimit.com